This consensus document outlines expert recommendations and future research directions for understanding and managing atherothrombosis and thromboembolism.
Answers are grounded in this paper and cite their sources.
Updates clinical decisions on atherothrombosis with expert consensus; extends research priorities on risk factors, cells, proteases, and novel antithrombotics.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Spronk et al. (2018) conducted a review in Atherothrombosis and Thromboembolism. The Second Maastricht Consensus Conference on Thrombosis established expert consensus recommendations regarding atherothrombosis risk factors, circulating cells, coagulation proteases, and novel antithrombotic treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: